Novartis' Cosentyx beats UCB drug to finish line as first new biologic for lesser-known skin condition in years
1st November 2023 Uncategorised 0 Novartis’ Cosentyx beats UCB drug to finish line as first new biologic for lesser-known skin condition in years
fkansteiner
Wed, 11/01/2023 – 09:03
More: Novartis' Cosentyx beats UCB drug to finish line as first new biologic for lesser-known skin condition in years
Source: fierce